Halyard Health (NYSE: HYH) and Orthofix International N.V. (NASDAQ:OFIX) are both medical equipment, supplies & distribution – nec companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings.

Volatility and Risk

Halyard Health has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500. Comparatively, Orthofix International N.V. has a beta of 0.15, indicating that its stock price is 85% less volatile than the S&P 500.

Valuation & Earnings

This table compares Halyard Health and Orthofix International N.V.’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Halyard Health $1.59 billion 1.34 $39.80 million $1.19 38.19
Orthofix International N.V. $409.79 million 2.38 $3.05 million $0.07 764.68

Halyard Health has higher revenue and earnings than Orthofix International N.V.. Halyard Health is trading at a lower price-to-earnings ratio than Orthofix International N.V., indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Halyard Health and Orthofix International N.V.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Halyard Health 3.52% 8.65% 4.69%
Orthofix International N.V. 0.33% 10.26% 7.57%

Institutional & Insider Ownership

91.7% of Halyard Health shares are owned by institutional investors. Comparatively, 92.8% of Orthofix International N.V. shares are owned by institutional investors. 1.3% of Halyard Health shares are owned by company insiders. Comparatively, 5.6% of Orthofix International N.V. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Halyard Health and Orthofix International N.V., as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Halyard Health 0 2 3 0 2.60
Orthofix International N.V. 0 0 5 0 3.00

Halyard Health presently has a consensus target price of $44.00, suggesting a potential downside of 3.19%. Orthofix International N.V. has a consensus target price of $53.30, suggesting a potential downside of 0.41%. Given Orthofix International N.V.’s stronger consensus rating and higher possible upside, analysts plainly believe Orthofix International N.V. is more favorable than Halyard Health.

Summary

Orthofix International N.V. beats Halyard Health on 9 of the 14 factors compared between the two stocks.

Halyard Health Company Profile

Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment’s products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.